Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New approach to assessing glaucoma risk may help physicians decide who needs treatment

14.09.2004


A new approach for assessing glaucoma risk factors could be the first step in helping ophthalmologists determine the risk of progression from ocular hypertension to glaucoma and blindness, according to an article published today in the September issue of the American Journal of Ophthalmology.



This new approach, which is based on the risk assessment principles advanced by the coronary heart disease model, could help physicians decide the level of risk in an individual patient and whether to begin treatment in order to prevent glaucoma onset and irreversible damage.

The approach is the focus of a multi-year continuing medical education (CME) initiative on "Treatment of Risk in the Glaucoma Continuum" jointly sponsored by the University of Medicine and Dentistry of New Jersey (UMDNJ)-New Jersey Medical School’s Institute of Ophthalmology and Visual Science, the UMDNJ-Center for Continuing and Outreach Education, and Medical Intervention Systems (MIS).


Glaucoma is a neurodegenerative disease that damages the optic nerve and can lead to blindness if left untreated. Because the disease has no symptoms, by the time it is detected, a patient already may have irreversible damage that can lead to vision loss. The risk factors for glaucoma include age, African American or Hispanic origin, family history, diabetes, hypertension, nearsightedness, trauma or injury to the eye, a thin cornea, or elevated pressure in the eye.

Glaucoma disease has several stages, beginning with people "suspected of having glaucoma." An individual in this category has one or more risk factors – such as ocular hypertension or high intraocular pressure (IOP) – but optic nerve changes are still undetectable. Patients in the next stage of the disease are "diagnosed with having glaucoma" because changes in the retinal nerve fiber or optic disc and visual function can be detected.

"Most clinicians recommend treatment once damage to the optic nerve head is detected or when IOP is high," said Robert D. Fechtner, MD, course director of the "Treatment of Risk in the Glaucoma Continuum" initiative, and professor of ophthalmology at the Institute of Ophthalmology and Visual Science at UMDNJ-New Jersey Medical School. "Although high IOP is clearly a risk factor, we know other factors also must be involved because even people with ’normal’ IOP can experience vision loss from glaucoma. This new approach should help us more clearly assess who is at risk, whom to treat and when to treat," said Fechtner.

The assessment of scientific risk for developing glaucoma was patterned on the model that has been used for many years in managing patients with cardiovascular disease. The heart study risk model is based on data from studies that identified key predictive risk factors for cardiovascular events, including the landmark, decades-long Framingham Heart Study.

"Global risk assessment in coronary heart disease provides an example of how the ability to detect and treat underlying factors can mark significant strides in the way a disease is managed," said AJO Perspectives article co-author William B. Kannel, MD, MPH, professor of medicine and public health at Boston University School of Medicine and senior investigator and director of the Visiting Scientist Program at the Framingham Heart Study. "Before Framingham, most physicians didn’t aggressively manage predisposing cholesterol levels or high blood pressure; they treated patients who had already suffered heart attacks or strokes. We hope that this glaucoma initiative and subsequent research will effect the same kind of shift toward prevention and earlier intervention for those at risk versus intervention at a later stage in the disease."

"This approach is a step forward in developing a scientific basis for deciding whether to treat a specific individual or not," said Robert N. Weinreb, MD, lead author of the AJO Perspectives article and program chair of the "Treatment of Risk in the Glaucoma Continuum" initiative. "In many respects clinical research in glaucoma faces the same challenges today that cardiovascular disease research faced 20 years ago. This approach has the potential to have the same impact for glaucoma as the Framingham Study had on cardiovascular medicine." Dr. Weinreb is the Director of the Hamilton Glaucoma Center and Professor of Ophthalmology at the University of California, San Diego.

Glaucoma affects approximately 3 million people in the U.S. and 67 million people worldwide. It is the second leading cause of blindness in the U.S. and the leading cause of preventable blindness. An estimated 120,000 Americans are blind from glaucoma, accounting for 9 percent to 12 percent of all cases of blindness in the U.S.

Kaylyn Dines | EurekAlert!
Further information:
http://www.umdnj.edu

More articles from Health and Medicine:

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

nachricht The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

Im Focus: Newly proposed reference datasets improve weather satellite data quality

UMD, NOAA collaboration demonstrates suitability of in-orbit datasets for weather satellite calibration

"Traffic and weather, together on the hour!" blasts your local radio station, while your smartphone knows the weather halfway across the world. A network of...

Im Focus: Repairing defects in fiber-reinforced plastics more efficiently

Fiber-reinforced plastics (FRP) are frequently used in the aeronautic and automobile industry. However, the repair of workpieces made of these composite materials is often less profitable than exchanging the part. In order to increase the lifetime of FRP parts and to make them more eco-efficient, the Laser Zentrum Hannover e.V. (LZH) and the Apodius GmbH want to combine a new measuring device for fiber layer orientation with an innovative laser-based repair process.

Defects in FRP pieces may be production or operation-related. Whether or not repair is cost-effective depends on the geometry of the defective area, the tools...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Multiregional brain on a chip

16.01.2017 | Power and Electrical Engineering

New technology enables 5-D imaging in live animals, humans

16.01.2017 | Information Technology

Researchers develop environmentally friendly soy air filter

16.01.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>